Comments on: Heavy Metal Content in Bhasma Preparations: Safety Data from ICP-MS Analytical Studies

By: Kevin Martin

Kevin Martin — Thu, 01 Oct 2026 18:48:30 +0000

Concerns about nanoparticle crossing barriers highlight a new research direction for Ayurvedic metal medicines.

By: Matthew Green

Matthew Green — Thu, 24 Sep 2026 01:02:11 +0000

Requesting a certificate of analysis from manufacturers adds a practical safety step.

By: Jason Miller

Jason Miller — Wed, 16 Sep 2026 17:05:49 +0000

The article’s breakdown of categories helps patients know which bhasma need specialist supervision.

By: Shruti Reddy

Shruti Reddy — Sat, 12 Sep 2026 17:07:33 +0000

Same here.

By: Indira Shah

Indira Shah — Fri, 11 Sep 2026 20:53:56 +0000

The ICP-MS methodology section is the most reassuring part of this — it’s the same analytical standard used for food safety testing, so the detection limits are meaningful. My concern is still about batch-to-batch variation even within a single manufacturer. Does the article mention whether multiple production batches were sampled?

By: Ashley Carter

Ashley Carter — Tue, 08 Sep 2026 18:55:43 +0000

It would be helpful to see more long term pharmacovigilance studies on Loh Bhasma iron accumulation.

By: Rebecca Turner

Rebecca Turner — Tue, 01 Sep 2026 02:01:20 +0000

Reading about Parada Bhasma’s low HgS absorption makes me think about dose limits more carefully.

By: Catherine Martin

Catherine Martin — Mon, 31 Aug 2026 20:16:27 +0000

@Jessica the study cited uses 40-day Bhasma. does preparation duration affect metal speciation and thus safety profile?

By: Sneha Kapoor

Sneha Kapoor — Sun, 30 Aug 2026 12:25:17 +0000

the ICP-NS data from research-grade Bhasma does not automatically apply to commercial products. quality control across Ayurvedic manufacturers is highly variable.

By: Jennifer Lee

Jennifer Lee — Tue, 25 Aug 2026 08:44:29 +0000

@Emily the study cited uses 40-day Bhasma. does preparation duration affect metal speciation and thus safety profile?